R&D

Apart from providing quality and affordable generic drugs to global healthcare systems, focus on R&D is a key value driver at Orchid. We recognise the importance of developing knowledge-intensive businesses as drivers of future growth. Through our discovery subsidiary, Orchid Research Laboratories Limited (Orchid Research), robust discovery and development platforms have been established in the areas of anti-infectives, anti-inflammatory, anti-ulcerants, anti-diabetes drugs and metabolic diseases. We have world-class R&D centres certified by the National GLP (Good Laboratory Practices) Authority of India for advanced chemical research and analytical development located at Shozhanganallur and Irungattukottai in Chennai.

Our scientific personnel comprise of over 600 scientists across the entire spectrum of R&D and analytical research, working in various areas of drug discovery and development in addition to CMC (chemistry, manufacturing and controls), pharma research and other related process and pharma research activities. Our people strive to create clinically differentiated drugs and diagnostics to help people live longer and healthier. To drive discovery and development, Orchid Research developed a proprietary product pipeline and collaborated with multinational companies for discovery of new chemical entities to undertake co-discovery and/or co-development projects, as well as provide custom research services.